FDA Advisers Recommend Approving First mRNA Influenza Vaccine

Moderna’s vaccine is the first influenza shot to contain messenger ribonucleic acid.

A healthcare worker in New York prepares a Moderna vaccine, in a file photo. Michael M. Santiago/Getty Images

The Food and Drug Administration should approve the first messenger ribonucleic acid (mRNA) vaccine for influenza, the agency’s vaccine advisory panel said on June 18.

The Vaccines and Related Biological Products Advisory Committee in a unanimous vote advised the FDA to approve an mRNA flu shot from Moderna for adults aged 50 and older.